Tianjin Pharmaceutical Da Ren Tang Group Corp Akcia Analýza akcií | Cena akcií | Novinky | 600329.SS | CNE000001808 |

Dátum	Tianjin Pharmaceutical Da Ren Tang Group Corp Tržby	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT	Tianjin Pharmaceutical Da Ren Tang Group Corp Zisk
2026e	10,96 mld. undefined	1,65 mld. undefined	1,73 mld. undefined
2025e	10,00 mld. undefined	1,34 mld. undefined	1,46 mld. undefined
2024e	9,12 mld. undefined	1,08 mld. undefined	1,21 mld. undefined
2023	8,22 mld. undefined	814,79 mil. undefined	986,71 mil. undefined
2022	8,25 mld. undefined	681,08 mil. undefined	861,79 mil. undefined
2021	6,91 mld. undefined	592,64 mil. undefined	769,14 mil. undefined
2020	6,60 mld. undefined	587,50 mil. undefined	661,70 mil. undefined
2019	6,99 mld. undefined	536,80 mil. undefined	625,60 mil. undefined
2018	6,36 mld. undefined	468,00 mil. undefined	561,70 mil. undefined
2017	5,69 mld. undefined	348,30 mil. undefined	476,10 mil. undefined
2016	6,24 mld. undefined	295,80 mil. undefined	423,60 mil. undefined
2015	7,08 mld. undefined	393,20 mil. undefined	451,40 mil. undefined
2014	7,09 mld. undefined	372,50 mil. undefined	357,80 mil. undefined
2013	6,01 mld. undefined	344,10 mil. undefined	351,80 mil. undefined
2012	5,13 mld. undefined	268,00 mil. undefined	441,30 mil. undefined
2011	4,39 mld. undefined	271,90 mil. undefined	247,60 mil. undefined
2010	3,47 mld. undefined	236,80 mil. undefined	293,30 mil. undefined
2009	2,88 mld. undefined	168,40 mil. undefined	257,80 mil. undefined
2008	2,37 mld. undefined	92,50 mil. undefined	176,10 mil. undefined
2007	2,26 mld. undefined	-185,70 mil. undefined	-70,00 mil. undefined
2006	2,16 mld. undefined	-408,20 mil. undefined	-386,60 mil. undefined
2005	2,52 mld. undefined	51,30 mil. undefined	80,80 mil. undefined
2004	2,12 mld. undefined	73,10 mil. undefined	64,00 mil. undefined

	Tržby	EBIT	Zisk
2004	2,12 mld. CNY	73,10 mil. CNY	64,00 mil. CNY
2005	2,52 mld. CNY	51,30 mil. CNY	80,80 mil. CNY
2006	2,16 mld. CNY	-408,20 mil. CNY	-386,60 mil. CNY
2007	2,26 mld. CNY	-185,70 mil. CNY	-70,00 mil. CNY
2008	2,37 mld. CNY	92,50 mil. CNY	176,10 mil. CNY
2009	2,88 mld. CNY	168,40 mil. CNY	257,80 mil. CNY
2010	3,47 mld. CNY	236,80 mil. CNY	293,30 mil. CNY
2011	4,39 mld. CNY	271,90 mil. CNY	247,60 mil. CNY
2012	5,13 mld. CNY	268,00 mil. CNY	441,30 mil. CNY
2013	6,01 mld. CNY	344,10 mil. CNY	351,80 mil. CNY
2014	7,09 mld. CNY	372,50 mil. CNY	357,80 mil. CNY
2015	7,08 mld. CNY	393,20 mil. CNY	451,40 mil. CNY
2016	6,24 mld. CNY	295,80 mil. CNY	423,60 mil. CNY
2017	5,69 mld. CNY	348,30 mil. CNY	476,10 mil. CNY
2018	6,36 mld. CNY	468,00 mil. CNY	561,70 mil. CNY
2019	6,99 mld. CNY	536,80 mil. CNY	625,60 mil. CNY
2020	6,60 mld. CNY	587,50 mil. CNY	661,70 mil. CNY
2021	6,91 mld. CNY	592,64 mil. CNY	769,14 mil. CNY
2022	8,25 mld. CNY	681,08 mil. CNY	861,79 mil. CNY
2023	8,22 mld. CNY	814,79 mil. CNY	986,71 mil. CNY
2024e	9,12 mld. CNY	1,08 mld. CNY	1,21 mld. CNY
2025e	10,00 mld. CNY	1,34 mld. CNY	1,46 mld. CNY
2026e	10,96 mld. CNY	1,65 mld. CNY	1,73 mld. CNY

Tianjin Pharmaceutical Da Ren Tang Group Corp Hrubá marža	Tianjin Pharmaceutical Da Ren Tang Group Corp Marža zisku	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT marža	Tianjin Pharmaceutical Da Ren Tang Group Corp Marža zisku
2026e	43,66 %	15,09 %	15,80 %
2025e	43,66 %	13,36 %	14,58 %
2024e	43,66 %	11,84 %	13,24 %
2023	43,66 %	9,91 %	12,00 %
2022	39,49 %	8,26 %	10,45 %
2021	39,76 %	8,58 %	11,13 %
2020	39,07 %	8,90 %	10,02 %
2019	41,76 %	7,68 %	8,94 %
2018	41,20 %	7,36 %	8,83 %
2017	38,68 %	6,12 %	8,37 %
2016	32,27 %	4,74 %	6,79 %
2015	29,48 %	5,55 %	6,38 %
2014	30,27 %	5,26 %	5,05 %
2013	31,86 %	5,73 %	5,85 %
2012	34,12 %	5,22 %	8,60 %
2011	34,85 %	6,19 %	5,64 %
2010	37,77 %	6,82 %	8,44 %
2009	37,54 %	5,85 %	8,95 %
2008	36,93 %	3,91 %	7,45 %
2007	34,28 %	-8,22 %	-3,10 %
2006	35,01 %	-18,86 %	-17,86 %
2005	42,58 %	2,04 %	3,21 %
2004	45,13 %	3,45 %	3,02 %

	Hrubá marža	EBIT marža	Marža zisku
2004	45,13 %	3,45 %	3,02 %
2005	42,58 %	2,04 %	3,21 %
2006	35,01 %	-18,86 %	-17,86 %
2007	34,28 %	-8,22 %	-3,10 %
2008	36,93 %	3,91 %	7,45 %
2009	37,54 %	5,85 %	8,95 %
2010	37,77 %	6,82 %	8,44 %
2011	34,85 %	6,19 %	5,64 %
2012	34,12 %	5,22 %	8,60 %
2013	31,86 %	5,73 %	5,85 %
2014	30,27 %	5,26 %	5,05 %
2015	29,48 %	5,55 %	6,38 %
2016	32,27 %	4,74 %	6,79 %
2017	38,68 %	6,12 %	8,37 %
2018	41,20 %	7,36 %	8,83 %
2019	41,76 %	7,68 %	8,94 %
2020	39,07 %	8,90 %	10,02 %
2021	39,76 %	8,58 %	11,13 %
2022	39,49 %	8,26 %	10,45 %
2023	43,66 %	9,91 %	12,00 %
2024e	43,66 %	11,84 %	13,24 %
2025e	43,66 %	13,36 %	14,58 %
2026e	43,66 %	15,09 %	15,80 %

Dátum	Tianjin Pharmaceutical Da Ren Tang Group Corp Tržby na akciu	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT na akciu	Tianjin Pharmaceutical Da Ren Tang Group Corp Zisk na akciu
2026e	14,25 undefined	0 undefined	2,25 undefined
2025e	13,01 undefined	0 undefined	1,90 undefined
2024e	11,86 undefined	0 undefined	1,57 undefined
2023	10,69 undefined	1,06 undefined	1,28 undefined
2022	10,63 undefined	0,88 undefined	1,11 undefined
2021	8,98 undefined	0,77 undefined	1,00 undefined
2020	8,59 undefined	0,76 undefined	0,86 undefined
2019	9,10 undefined	0,70 undefined	0,81 undefined
2018	8,26 undefined	0,61 undefined	0,73 undefined
2017	7,40 undefined	0,45 undefined	0,62 undefined
2016	8,12 undefined	0,38 undefined	0,55 undefined
2015	9,21 undefined	0,51 undefined	0,59 undefined
2014	9,59 undefined	0,50 undefined	0,48 undefined
2013	8,13 undefined	0,47 undefined	0,48 undefined
2012	6,94 undefined	0,36 undefined	0,60 undefined
2011	5,94 undefined	0,37 undefined	0,33 undefined
2010	4,70 undefined	0,32 undefined	0,40 undefined
2009	3,90 undefined	0,23 undefined	0,35 undefined
2008	3,20 undefined	0,13 undefined	0,24 undefined
2007	3,05 undefined	-0,25 undefined	-0,09 undefined
2006	2,93 undefined	-0,55 undefined	-0,52 undefined
2005	3,40 undefined	0,07 undefined	0,11 undefined
2004	2,86 undefined	0,10 undefined	0,09 undefined

	Tržby na akciu	EBIT na akciu	Zisk na akciu
2004	2,86 CNY	0,10 CNY	0,09 CNY
2005	3,40 CNY	0,07 CNY	0,11 CNY
2006	2,93 CNY	-0,55 CNY	-0,52 CNY
2007	3,05 CNY	-0,25 CNY	-0,09 CNY
2008	3,20 CNY	0,13 CNY	0,24 CNY
2009	3,90 CNY	0,23 CNY	0,35 CNY
2010	4,70 CNY	0,32 CNY	0,40 CNY
2011	5,94 CNY	0,37 CNY	0,33 CNY
2012	6,94 CNY	0,36 CNY	0,60 CNY
2013	8,13 CNY	0,47 CNY	0,48 CNY
2014	9,59 CNY	0,50 CNY	0,48 CNY
2015	9,21 CNY	0,51 CNY	0,59 CNY
2016	8,12 CNY	0,38 CNY	0,55 CNY
2017	7,40 CNY	0,45 CNY	0,62 CNY
2018	8,26 CNY	0,61 CNY	0,73 CNY
2019	9,10 CNY	0,70 CNY	0,81 CNY
2020	8,59 CNY	0,76 CNY	0,86 CNY
2021	8,98 CNY	0,77 CNY	1,00 CNY
2022	10,63 CNY	0,88 CNY	1,11 CNY
2023	10,69 CNY	1,06 CNY	1,28 CNY
2024e	11,86 CNY	0 CNY	1,57 CNY
2025e	13,01 CNY	0 CNY	1,90 CNY
2026e	14,25 CNY	0 CNY	2,25 CNY

	Počet akcií
2004	739,30 mil. Aktien
2005	739,30 mil. Aktien
2006	739,30 mil. Aktien
2007	739,30 mil. Aktien
2008	739,30 mil. Aktien
2009	739,30 mil. Aktien
2010	739,30 mil. Aktien
2011	739,30 mil. Aktien
2012	739,30 mil. Aktien
2013	739,30 mil. Aktien
2014	739,30 mil. Aktien
2015	768,90 mil. Aktien
2016	768,90 mil. Aktien
2017	768,90 mil. Aktien
2018	769,40 mil. Aktien
2019	768,90 mil. Aktien
2020	768,90 mil. Aktien
2021	769,14 mil. Aktien
2022	776,39 mil. Aktien
2023	768,87 mil. Aktien
2024e	768,87 mil. Aktien
2025e	768,87 mil. Aktien
2026e	768,87 mil. Aktien

Dátum	Tianjin Pharmaceutical Da Ren Tang Group Corp Dividenda
2026e	1,21 undefined
2025e	1,21 undefined
2024e	1,21 undefined
2023	1,12 undefined
2022	0,50 undefined
2021	0,30 undefined
2020	0,30 undefined
2019	0,22 undefined
2018	0,20 undefined
2017	0,15 undefined
2016	0,25 undefined
2015	0,15 undefined
2014	0,05 undefined
2013	0,10 undefined
2012	0,20 undefined
2011	0,20 undefined
2006	0,08 undefined
2005	0,08 undefined
2004	0,08 undefined

	Dividenda	Dividenda (odhad)
2004	0,08 CNY	0 CNY
2005	0,08 CNY	0 CNY
2006	0,08 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0,20 CNY	0 CNY
2012	0,20 CNY	0 CNY
2013	0,10 CNY	0 CNY
2014	0,05 CNY	0 CNY
2015	0,15 CNY	0 CNY
2016	0,25 CNY	0 CNY
2017	0,15 CNY	0 CNY
2018	0,20 CNY	0 CNY
2019	0,22 CNY	0 CNY
2020	0,30 CNY	0 CNY
2021	0,30 CNY	0 CNY
2022	0,50 CNY	0 CNY
2023	1,12 CNY	0 CNY
2024e	0 CNY	1,21 CNY
2025e	0 CNY	1,21 CNY
2026e	0 CNY	1,21 CNY

Dátum	Tianjin Pharmaceutical Da Ren Tang Group Corp Výplatný pomer
2026e	37,84 %
2025e	39,64 %
2024e	37,23 %
2023	36,64 %
2022	45,05 %
2021	30,00 %
2020	34,88 %
2019	27,16 %
2018	27,40 %
2017	24,19 %
2016	45,45 %
2015	25,42 %
2014	10,42 %
2013	20,83 %
2012	33,33 %
2011	60,61 %
2010	36,64 %
2009	36,64 %
2008	36,64 %
2007	36,64 %
2006	-14,42 %
2005	68,18 %
2004	83,33 %

	Výplatný pomer
2004	83,33 %
2005	68,18 %
2006	-14,42 %
2007	36,64 %
2008	36,64 %
2009	36,64 %
2010	36,64 %
2011	60,61 %
2012	33,33 %
2013	20,83 %
2014	10,42 %
2015	25,42 %
2016	45,45 %
2017	24,19 %
2018	27,40 %
2019	27,16 %
2020	34,88 %
2021	30,00 %
2022	45,05 %
2023	36,64 %
2024e	37,23 %
2025e	39,64 %
2026e	37,84 %

Dátum	Odhad EPS	EPS-Aktuálny	spravodajské štvrťrok
31. 12. 2014	0,22	0,13 (-41,49 %)	2014 Q4
30. 9. 2014	0,18	0,08 (-56,00 %)	2014 Q3
30. 6. 2014	0,15	0,13 (-14,19 %)	2014 Q2
31. 12. 2013	0,21	0,16 (-24,56 %)	2013 Q4
30. 9. 2013	0,14	0,06 (-57,57 %)	2013 Q3
30. 6. 2013	0,13	0,10 (-20,82 %)	2013 Q2

%	Meno	Akciové spoločnosti	Zmena	Dátum
42,38 %	Tianjin Pharmaceutical Holdings Ltd.	325 855 528	0	31. 12. 2023
1,09 %	Fullgoal Fund Management Co., Ltd.	8 392 119	-340 800	31. 12. 2023
0,70 %	Zhong Ou Asset Management Co., Ltd.	5 348 982	-8 489 300	31. 12. 2023
0,61 %	GF Fund Management Co., Ltd.	4 711 501	-1 989 900	31. 12. 2023
0,57 %	Chen (Shihui)	4 418 118	4 418 118	31. 12. 2023
0,54 %	China Universal Asset Management Co., Ltd.	4 124 015	-422 094	31. 12. 2023
0,31 %	Hotland Innovation Asset Management Co., Ltd.	2 413 803	-230 080	31. 12. 2023
0,29 %	E Fund Management Co. Ltd.	2 252 050	-2 748 720	30. 6. 2023
0,29 %	China Southern Asset Management Co. Ltd.	2 228 492	117 800	31. 12. 2023
0,27 %	ICBC Credit Suisse Asset Management Co. Ltd.	2 107 589	-243 100	31. 12. 2023
0,23 %	Cinda Fund Management Co., Ltd.	1 805 256	-2 020 600	31. 12. 2023
0,22 %	China Asset Management Co., Ltd.	1 722 109	53 900	31. 12. 2023
0,21 %	Bosera Asset Management Co., Ltd.	1 589 300	-30 200	31. 12. 2023
0,20 %	Penghua Fund Management Co., Ltd.	1 510 738	310 800	30. 6. 2023
0,19 %	ZhongRong Fund Mgmt Co., Ltd	1 434 538	-638 862	30. 6. 2023
0,17 %	The Vanguard Group, Inc.	1 311 297	0	31. 3. 2024
0,16 %	JPMorgan Asset Management (China) Company Limited.	1 254 249	1 214 649	30. 6. 2023
0,15 %	China Merchants Fund Management Co. Ltd.	1 153 883	-160 300	31. 12. 2023
0,14 %	Western Leadbank Fund Management Co., Ltd.	1 040 100	1 040 100	30. 6. 2023
0,12 %	CCB Principal Asset Management Co., Ltd.	913 135	103 700	31. 12. 2023
0,11 %	AXA-SPDB Investment Managers Co., Ltd.	813 400	695 400	31. 12. 2023
0,10 %	Harvest Fund Management Co., Ltd.	803 209	-741 615	30. 6. 2023
0,09 %	Guotai Junan Securities Assets Management Co., Ltd.	692 400	692 400	30. 6. 2023
0,09 %	Broad Asset Management Co., Ltd	686 600	686 600	30. 6. 2023
0,08 %	Great Wall Fund Management Co., Ltd.	628 300	-21 700	31. 12. 2023
0,08 %	Tianhong Asset Management Co., Ltd.	579 300	14 300	31. 12. 2023
0,07 %	CITIC Prudential Fund Management Co., Ltd.	560 672	500 000	31. 12. 2023
0,07 %	Zhong Hai Fund Management Co., Ltd.	548 127	548 127	31. 12. 2023
0,06 %	Changsheng Fund Management Co., Ltd.	498 100	-25 400	31. 12. 2023
0,06 %	Morgan Stanley Investment Management (China) Company Limited.	480 200	30 300	30. 6. 2023
0,06 %	Founder Fubon Fund Management Co., Ltd.	460 677	0	31. 12. 2023
0,06 %	Norges Bank Investment Management (NBIM)	458 108	458 108	31. 12. 2023
0,05 %	First-Trust Fund Management Co., Ltd.	388 188	-157 228	30. 6. 2023
0,05 %	Hongde Fund Management Co., Ltd.	349 200	-696 900	30. 6. 2023
0,04 %	Bank of Communications Schroder Fund Management Co., Ltd.	297 773	-5 088 456	30. 6. 2023
0,04 %	Baoying Fund Management Co., Ltd.	273 100	-499 300	31. 12. 2023
0,03 %	Dacheng Fund Management Co., Ltd.	260 201	256 600	30. 6. 2023
0,03 %	Value Partners Ltd.	246 572	-41 400	31. 12. 2023
0,03 %	Maxwealth Fund Management Co., Ltd.	220 000	218 100	30. 6. 2023
0,03 %	Chang Xin Asset Management Co., Ltd.	212 000	-269 200	31. 12. 2023
0,03 %	PengYang Asset Management Co., Ltd	207 000	207 000	30. 6. 2023
0,03 %	Huashang Fund Management Co., Ltd.	200 000	200 000	30. 6. 2023
0,03 %	Dimensional Fund Advisors, L.P.	198 372	-200	29. 2. 2024
0,03 %	Yinhua Fund Management Co., Ltd.	198 031	125 400	31. 12. 2023
0,03 %	Everbright PGIM Fund Management Co., Ltd.	197 000	-179 100	30. 6. 2023
0,02 %	CICC Fund Management Co Ltd.	170 700	-6 500	31. 12. 2023
0,02 %	INVESCO Great Wall Fund Management Co. Ltd.	167 255	-3 200	31. 12. 2023
0,02 %	Wanjia Asset Management Co., Ltd.	167 159	-2 781 983	30. 6. 2023
0,02 %	BOC International (China) Ltd.	142 800	200	31. 12. 2023
0,02 %	Hwabao WP Fund Management Co., Ltd.	116 000	90 000	31. 12. 2023
0,01 %	Huatai-PineBridge Fund Management Co., Ltd.	112 780	-214 603	30. 6. 2023
0,01 %	TongTai Asset Management Co., Ltd.	103 700	103 700	30. 6. 2023
0,01 %	Focusbridge Investments Limited	98 000	98 000	30. 6. 2023
0,01 %	Orient Securities Asset Management Company Limited	95 600	95 600	30. 6. 2023
0,01 %	Handelsbanken Kapitalförvaltning AB	95 500	0	31. 3. 2024
0,01 %	UBS SDIC Fund Management Co., Ltd.	92 800	15 100	31. 12. 2023
0,01 %	BOSC Asset Management Co., Ltd.	87 700	-33 600	31. 12. 2023
0,01 %	Ping An Fund Management Company Limited	77 400	-6 200	31. 12. 2023
0,01 %	ABC-CA Fund Management Co., Ltd.	68 100	-2 897 300	31. 12. 2023
0,01 %	Xinghua Fund Management Co., Ltd.	48 200	48 200	30. 6. 2023
0,01 %	Soochow Asset Management Co., Ltd.	47 200	-34 900	31. 12. 2023
0,01 %	China Fund Management Co., Ltd.	41 600	-28 600	31. 12. 2023
0,01 %	Guotai Asset Management Co., Ltd.	38 700	-445 509	30. 6. 2023
0,00 %	BlackRock Investment Management (UK) Ltd.	38 200	0	29. 2. 2024
0,00 %	SWS MU Fund Management Co., Ltd.	33 300	33 300	30. 6. 2023
0,00 %	JX Asset Management Co., Ltd.	32 078	-84 800	30. 6. 2023
0,00 %	Topsperity Fund Management Co., Ltd.	31 900	22 300	31. 12. 2023
0,00 %	Taikang Asset Management Co., Ltd.	28 100	25 000	31. 12. 2023
0,00 %	CITIC Securities Co., Ltd. (Asset Management)	27 600	27 600	30. 6. 2023
0,00 %	Donghai Funds Management Co., Ltd.	26 800	26 800	30. 6. 2023
0,00 %	Manulife Fund Management Co., Ltd.	25 700	1 000	31. 12. 2023
0,00 %	Sealand Securities Co., Ltd.	23 849	14 349	30. 6. 2023
0,00 %	Zhou (Hong)	23 800	-46 200	31. 12. 2023
0,00 %	Wang (Xin)	23 800	-46 200	31. 12. 2023
0,00 %	Niu (Sheng Fang)	23 800	-46 200	31. 12. 2023
0,00 %	Horizon Asset Management Co., Ltd.	20 700	-4 100	30. 6. 2023
0,00 %	AVIC Fund Management Co., Ltd.	18 700	12 600	30. 6. 2023
0,00 %	Caitong Fund Management Co., Ltd.	18 100	-31 200	31. 12. 2023
0,00 %	China Life AMP Asset Management Co., Ltd	17 200	-300	31. 12. 2023
0,00 %	China Everbright Assets Management, Ltd.	17 000	17 000	30. 6. 2023
0,00 %	HuaAn Fund Management Co., Ltd.	16 900	-1 328 600	30. 6. 2023
0,00 %	Goldstate Capital Fund Management Co., Ltd.	15 000	15 000	30. 6. 2023
0,00 %	CPIC Fund Management Co., Ltd.	14 500	14 500	30. 6. 2023
0,00 %	DBX Advisors LLC.	13 900	13 900	29. 2. 2024
0,00 %	Nykredit Bank AS	13 400	0	29. 2. 2024
0,00 %	Dimensional Fund Advisors, Ltd.	13 000	-6 600	29. 2. 2024
0,00 %	Minsheng Royal Fund Management Company Ltd.	12 200	4 800	30. 6. 2023
0,00 %	Neuberger Berman Fund Management (China) Co., Ltd.	11 739	11 739	30. 6. 2023
0,00 %	Truvalue Asset Management Co., Ltd.	10 500	-1 186 838	30. 6. 2023
0,00 %	Jiao (Yan)	10 200	-19 800	31. 12. 2023
0,00 %	Shanghai Haitong Securities Asset Management Ltd.	10 100	-3 800	31. 12. 2023
0,00 %	Tibet Eastmoney Fund Management Co., Ltd.	9 500	-100	30. 6. 2023
0,00 %	Xingyin Fund Management Co., Ltd.	9 300	9 300	30. 6. 2023
0,00 %	Orient Fund Management Co. Ltd.	9 000	-70 000	30. 6. 2023
0,00 %	Harvest Global Investments Limited	7 162	0	29. 2. 2024
0,00 %	Jyah Asset Management.Co.,LTD	7 000	5 500	30. 6. 2023
0,00 %	Golden Trust Sinopac Fund Management Co., Ltd.	6 500	6 500	30. 6. 2023
0,00 %	Essence Fund Management Co., Ltd.	6 100	-9 400	31. 12. 2023
0,00 %	Everbright Securities Asset Management Co., Ltd.	5 800	-5 900	31. 12. 2023
0,00 %	Northeast Ronghui Securities Asset Management Co., Ltd.	4 900	4 900	30. 6. 2023

Meno	Vzťah	Dvojtýždňová korelácia	Mesačná korelácia	Trojmesačná korelácia	Šesťmesačná korelácia	Jednoročná korelácia	Dvojročná korelácia
Citigroup	DodávateľKlient	0,69	-0,04	0,80	0,66	0,43	0,57
GlaxoSmithKline	DodávateľKlient	0,36	-0,43	-0,80	-0,59	-0,42	0,31
Standard Chartered	DodávateľKlient	0,33	0,71	-0,68	-0,32	-0,34	0,26
Tianjin Lisheng Pharm A	DodávateľKlient	0,12	0,91	0,83	0,28	0,17	-0,40
Tianjin Development Hldgs	DodávateľKlient	0,05	-0,58	0,72	0,34	0,18	0,54
DBS Group Holdings	DodávateľKlient	-0,53	-0,72	0,53	0,47	0,02	0,75
ABN AMRO DR	DodávateľKlient	-0,70	-0,75	-0,21	0,60	0,30	0,78

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd represents values of innovation, integrity, and quality in the pharmaceutical industry. With a strong corporate philosophy focused on delivering cutting-edge healthcare solutions, the company strives to provide safe and effective pharmaceutical products to improve people's well-being. Tianjin Zhongxin Pharmaceutical Group Corp Ltd's commitment to research and development, along with its dedication to meeting international standards, has positioned the company as a leader in the global pharmaceutical market. Through its emphasis on quality control, continuous improvement, and customer satisfaction, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the delivery of reliable and trustworthy healthcare solutions.

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is primarily present in China.

What significant milestones has the company Tianjin Pharmaceutical Da Ren Tang Group Corp achieved?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd has achieved several significant milestones. It has successfully expanded its product portfolio, notably in the areas of cardiovascular, respiratory, and anti-infective medicines. The company has also secured numerous international certifications, including Good Manufacturing Practice (GMP) certification, ensuring the highest quality standards. Tianjin Zhongxin Pharmaceutical Group Corp Ltd has made remarkable strides in research and development as well, with several innovative drugs being registered and commercialized. Furthermore, the company has established a robust global presence by entering into strategic partnerships and expanding its market reach. These achievements consolidate Tianjin Zhongxin Pharmaceutical Group Corp Ltd's position as a leading player in the pharmaceutical industry.

What is the history and background of the company Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, a leading pharmaceutical company, has a rich history and background. Established in [year], the company has been dedicated to providing high-quality healthcare products and services to global markets. With a focus on research and development, manufacturing, and marketing, Tianjin Zhongxin has emerged as a trusted name in the pharmaceutical industry. Its commitment to innovation, quality, and customer satisfaction has enabled it to expand its presence both domestically and internationally. Being one of the prominent players in the pharmaceutical market, Tianjin Zhongxin Pharmaceutical Group Corp Ltd continuously strives for excellence through its diverse product portfolio and relentless pursuit of breakthrough solutions in healthcare.

Who are the main competitors of Tianjin Pharmaceutical Da Ren Tang Group Corp in the market?

The main competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd in the market include other leading pharmaceutical companies such as Shanghai Pharmaceuticals Holding Co., Ltd., Sinopharm Group Co., Ltd., Fosun Pharma, and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily active?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd primarily operates in the pharmaceutical industry.

What is the business model of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd focuses on the development, production, and sales of pharmaceutical products. As one of the leading pharmaceutical companies in China, Tianjin Zhongxin Pharmaceutical Group Corp Ltd aims to provide high-quality and affordable medications to improve the health and well-being of individuals. With a diverse product portfolio ranging from traditional Chinese medicine to modern pharmaceuticals, the company emphasizes research and innovation to meet the growing healthcare needs of its customers. By adhering to strict quality standards and maintaining a strong distribution network, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the availability and accessibility of its products nationwide.

Aké P/E má Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Pomer Tianjin Pharmaceutical Da Ren Tang Group Corp cena/zisk je 20,79.

Aké KUV má Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Koeficient Tianjin Pharmaceutical Da Ren Tang Group Corp P/S je 2,75.

Aký AlleAktien kvalitatívny skóre má Tianjin Pharmaceutical Da Ren Tang Group Corp?

AlleAktien kvalitatívne skóre pre Tianjin Pharmaceutical Da Ren Tang Group Corp je 7/10.

Aká je výška tržieb spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Tržby spoločnosti očakávaná Tianjin Pharmaceutical Da Ren Tang Group Corp sú 9,12 mld. CNY.

Aká je výška zisku spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Zisk očakávaná Tianjin Pharmaceutical Da Ren Tang Group Corp je 1,21 mld. CNY.

Čo robí Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a Chinese company specialized in the production and sale of pharmaceutical products, health and dietary supplements, and medical devices. Its business model is based on a comprehensive range of products and services that allow it to meet the needs of customers in different markets. The company is divided into several divisions, including the pharmaceutical products division, the dietary supplements division, and the medical devices division. Each of these divisions offers unique products and services tailored to specific needs and requirements. In the field of pharmaceutical products, Tianjin Zhongxin Pharmaceutical Group Corp Ltd manufactures a variety of drugs used to treat various diseases and conditions. This includes antibiotics, anti-inflammatory drugs, cancer medications, as well as treatments for cardiovascular diseases and diabetes. The company also has a research and development department that continuously works on the development of new drugs. The dietary supplements division offers a wide range of products aimed at improving health and well-being. These include vitamins, minerals, enzymes, and herbal extracts. The company adheres to strict standards in the production of its products and uses only high-quality and natural ingredients. The medical devices division of Tianjin Zhongxin Pharmaceutical Group Corp Ltd specializes in the production of medical devices such as blood glucose monitors and blood pressure monitors. These devices are of high quality and comply with all applicable standards and regulations. The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd also includes collaborations with other companies and organizations around the world. The company has partnerships with a variety of domestic and international companies to expand its product range and strengthen its global presence. Overall, the business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is focused on the development, production, and sale of high-quality pharmaceutical products, dietary supplements, and medical devices. Its divisions offer a wide range of products and services tailored to the needs of customers in different markets. Through its global presence and collaborations with other companies and organizations worldwide, the company ensures continuous expansion and future success.

Aká vysoká je Tianjin Pharmaceutical Da Ren Tang Group Corp dividenda?

Tianjin Pharmaceutical Da Ren Tang Group Corp vypláca dividendu vo výške 0,50 CNY rozdelenú do výplat počas roka.

Ako často vypláca Tianjin Pharmaceutical Da Ren Tang Group Corp dividendu?

Dividenda pre Tianjin Pharmaceutical Da Ren Tang Group Corp sa aktuálne nedá vypočítať alebo spoločnosť nevypláca dividendu.

Aká je Tianjin Pharmaceutical Da Ren Tang Group Corp ISIN?

ISIN spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp je CNE000001808.

Aký je Tianjin Pharmaceutical Da Ren Tang Group Corp ticker?

Ticker spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp je 600329.SS.

Akú dividendu platí Tianjin Pharmaceutical Da Ren Tang Group Corp?

V posledných 12 mesiacoch spoločnosť Tianjin Pharmaceutical Da Ren Tang Group Corp vyplatila dividendu vo výške 1,12 CNY . To zodpovedá dividendovému výnosu približne 3,43 %. Pre nadchádzajúcich 12 mesiacov bude pravdepodobne spoločnosť Tianjin Pharmaceutical Da Ren Tang Group Corp vyplácať dividendu 1,21 CNY.

Aká je dividendová výnosnosť spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp?

Súčasný výnos z dividend spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp je 3,43 %.

Kedy vypláca Tianjin Pharmaceutical Da Ren Tang Group Corp dividendu?

Tianjin Pharmaceutical Da Ren Tang Group Corp vypláca dividendu každý štvrťrok. Tá je vyplácaná v mesiacoch júl, júl, júl, júl.

Ako istá je dividenda spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp platil každý rok počas posledných 16 rokov dividendu.

Aká vysoká je dividenda spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp?

Na nasledujúcich 12 mesiacov sa očakávajú dividendy vo výške 1,21 CNY. To zodpovedá dividendovému výnosu 3,70 %.

V ktorom sektore sa nachádza Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp je priradený sektoru 'Zdravie'.

Wann musste ich die Aktien von Tianjin Pharmaceutical Da Ren Tang Group Corp kaufen, um die vorherige Dividende zu erhalten?

Aby ste obdržali poslednú dividendu vo výške 1,12 CNY od Tianjin Pharmaceutical Da Ren Tang Group Corp z dňa 6. 6. 2023, museli ste mať akciu v depozite pred ex-dňom 6. 6. 2023.

Kedy poslednýkrát Tianjin Pharmaceutical Da Ren Tang Group Corp vyplatil dividendu?

Posledná dividenda bola vyplatená 6. 6. 2023.

Aká bola dividenda spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp v roku 2023?

V roku 2023 boli od Tianjin Pharmaceutical Da Ren Tang Group Corp 0,5 CNY vyplatené ako dividendy.

V akej mene vypláca Tianjin Pharmaceutical Da Ren Tang Group Corp dividendu?

Dividendy spoločnosti Tianjin Pharmaceutical Da Ren Tang Group Corp sú vyplácané v CNY.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	769,00	861,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123,00	114,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10,00	-56,00
-84,00	-198,00	-353,00	-350,00	-462,00	-536,00	-667,00	-682,00	-493,00	-471,00	-629,00	-611,00	-737,00	-884,00	-1 370,00	-1 547,00	-1 679,00	-1 664,00	-1 816,00	-2 084,00	-2 305,00	-2 068,00	-2 316,00	-2 255,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-186,00	-191,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-59,00	-93,00	-146,00	-162,00	-180,00	-203,00	-178,00	-198,00	-197,00	-260,00	-254,00	-328,00	-374,00	-424,00	-495,00	-511,00	-505,00	-487,00	-514,00	-554,00	-598,00	-523,00	-496,00	-526,00
69,00	-14,00	157,00	187,00	76,00	10,00	261,00	-28,00	20,00	113,00	83,00	139,00	173,00	20,00	213,00	286,00	360,00	417,00	-4,00	350,00	495,00	671,00	852,00	677,00
-54,00	-79,00	-134,00	-180,00	-589,00	-252,00	-149,00	-63,00	-53,00	-38,00	-86,00	-68,00	-43,00	-41,00	-72,00	-70,00	-92,00	-118,00	-114,00	-175,00	-205,00	-189,00	-156,00	-107,00
74,00	22,00	-67,00	-114,00	-654,00	-109,00	-61,00	120,00	253,00	97,00	22,00	11,00	33,00	22,00	-166,00	102,00	-428,00	86,00	197,00	382,00	-100,00	73,00	-311,00	-12,00
128,00	101,00	66,00	65,00	-65,00	143,00	88,00	184,00	307,00	135,00	108,00	80,00	76,00	63,00	-93,00	172,00	-335,00	204,00	311,00	557,00	104,00	262,00	-154,00	95,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-22,00	-1,00	-244,00	51,00	564,00	114,00	64,00	-51,00	-145,00	-162,00	-49,00	-80,00	5,00	63,00	185,00	-273,00	-367,00	-19,00	-42,00	-10,00	-222,00	0	0	179,00
14,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-83,00	-85,00	54,00	-22,00	505,00	-4,00	-67,00	-187,00	-234,00	-246,00	-86,00	-120,00	-197,00	-75,00	266,00	-491,00	273,00	-339,00	-161,00	-252,00	-370,00	-237,00	-244,00	-236,00
-75,00	-83,00	369,00	22,00	28,00	9,00	5,00	0	0	0	19,00	4,00	1,00	0	239,00	-99,00	784,00	-114,00	8,00	-77,00	25,00	-4,00	-12,00	-29,00
0	0	-69,00	-96,00	-87,00	-128,00	-136,00	-136,00	-89,00	-84,00	-56,00	-45,00	-204,00	-138,00	-157,00	-118,00	-143,00	-205,00	-127,00	-164,00	-173,00	-232,00	-232,00	-387,00
0,27	0,20	0,80	0,75	0,65	0,65	1,24	0,76	0,75	0,81	0,99	1,11	1,30	1,30	2,39	2,24	2,75	2,73	2,36	3,47	3,42	3,77	3,96	3,89
14,80	-93,90	23,70	7,20	-512,60	-241,80	112,10	-91,80	-33,60	75,40	-3,30	70,20	130,90	-20,40	141,00	216,70	268,00	299,60	-118,40	174,30	289,90	482,20	695,45	569,34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Priame emisie	—
Nepriame emisie z nakúpenej energie	—
Nepriame emisie v rámci hodnotového reťazca	—
Emisie CO₂	—
Stratégia redukcie CO₂	✅
Uhlená energia	❌
Atómová energia	❌
Pokúsy na zvieratách	✅
Pelz & Leder	—
Pesticídy	—
Palmový olej	—
Tabak	❌
Géntechnológia	❌
Koncept klímy	—
Udržateľné lesníctvo	—
Recyklačné predpisy	❌
Ekologické obaly	❌
Nebezpečné látky	❌
Spotreba a účinnosť paliva	❌
Spotreba a efektívnosť vody	✅

Podiel žien zamestnancov	—
Podiel žien v manažmente	—
Podiel ázijských zamestnancov	—
Podiel ázijského manažmentu	—
Podiel hispánskych/latinoamerických zamestnancov	—
Podiel hispánskeho/latinského manažmentu	—
Podiel zamestnancov čiernej pleti	—
Podiel čierneho manažmentu	—
Podiel bielych zamestnancov	—
Podiel bieleho vedenia	—
Dospelých obsah	❌
Alkohol	❌
obrana	—
strelne zbrane	❌
Hazard	❌
Vojenské zmluvy	❌
Koncept ľudských práv	❌
Koncept ochrany údajov	—
Ochrana práce a zdravia	✅
katolícky	✅

Udržateľnostná správa	✅
Angažovanosť zainteresovaných strán	❌
Spätné volacie pravidlá	❌
Antimonopolné právo	❌

Tianjin Pharmaceutical Da Ren Tang Group Corp Ticker	Tianjin Pharmaceutical Da Ren Tang Group Corp FIGI
600329:CH	BBG000CWRRB4
600329:CG	BBG000CWRRX0
600329:C1	BBG00709HMS7

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,29	0,41	0,82	1,52	1,84	2,06	2,12	2,52	2,16	2,26	2,37	2,88	3,47	4,39	5,13	6,01	7,09	7,08	6,24	5,69	6,36	6,99	6,60	6,91	8,25	8,22	9,12	10,00	10,96
-	44,06	99,51	85,04	20,91	12,23	2,47	19,01	-14,02	4,34	4,74	21,78	20,59	26,43	16,81	17,18	17,90	-0,08	-11,84	-8,86	11,76	9,99	-5,58	4,60	19,43	-0,33	10,92	9,66	9,58
49,65	50,49	42,58	37,48	36,81	41,72	45,11	42,55	34,98	34,28	36,91	37,53	37,75	34,84	34,12	31,85	30,27	29,48	32,27	38,67	41,19	41,76	39,07	39,76	39,48	43,66	-	-	-
0,14	0,21	0,35	0,57	0,68	0,86	0,95	1,07	0,76	0,77	0,87	1,08	1,31	1,53	1,75	1,91	2,15	2,09	2,01	2,20	2,62	2,92	2,58	2,75	3,26	3,59	0	0	0
0,03	0,04	0,04	0,06	0,06	0,07	0,07	0,05	-0,41	-0,19	0,09	0,17	0,24	0,27	0,27	0,34	0,37	0,39	0,30	0,35	0,47	0,54	0,59	0,59	0,68	0,81	1,08	1,34	1,65
11,19	9,71	4,50	3,81	3,15	3,54	3,45	2,03	-18,85	-8,19	3,89	5,83	6,80	6,17	5,23	5,72	5,25	5,55	4,73	6,12	7,36	7,66	8,89	8,57	8,26	9,90	11,84	13,36	15,09
0,15	0,11	0,09	0,06	0,09	0,09	0,06	0,08	-0,39	-0,07	0,18	0,26	0,29	0,25	0,44	0,35	0,36	0,45	0,42	0,48	0,56	0,63	0,66	0,77	0,86	0,99	1,21	1,46	1,73
-	-22,45	-24,56	-26,74	34,92	1,18	-25,58	25,00	-582,50	-81,87	-351,43	46,02	14,01	-15,70	78,54	-20,41	1,71	26,33	-6,21	12,53	17,86	11,41	5,76	16,34	11,96	14,52	22,41	20,80	18,72
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
659,30	659,30	659,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	768,90	768,90	768,90	769,40	768,90	768,90	769,14	776,39	768,87	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Urob najlepšie investície svojho života

Cena

Cena

Ticker600329.SS

ISINCNE000001808

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcia Obrat, EBIT, Zisk CNE000001808 ·

Tržby, Zisk & EBIT

Porozumenie tržbám, EBIT a príjmu

Ročná analýza a porovnania

Využitie očakávaní pre investície

Investičné vhľady

Tianjin Pharmaceutical Da Ren Tang Group Corp Tržby, zisk a história EBIT

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcie - Kľúčové ukazovatele

GuV

Tržby a rast

Hrubá marža

EBIT a marža EBIT

Príjem a rast

Počet akcií v obehu

Interpretácia ročných porovnaní

Očakávania a prognózy

Bilancia

Porozumenie bilancii

Aktíva

Záväzky

Vlastné imanie

Analýza rok za rokom

Interpretácia dát

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcie Marže CNE000001808 ·

Marže

Počítať brutto maržu

Analýza marže EBIT

Pohľady na maržu tržieb

Interpretácia očakávaní

Porovnávacia analýza

Tianjin Pharmaceutical Da Ren Tang Group Corp História marže

Tianjin Pharmaceutical Da Ren Tang Group Corp Akciový obrat, EBIT, zisk na akciu CNE000001808 ·

Tržby, EBIT a Zisk na akciu

Tržby na akciu

EBIT na akciu

Príjem na akciu

Očakávané hodnoty

Tianjin Pharmaceutical Da Ren Tang Group Corp Tržby, zisk a EBIT na akciu História

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcia a analýza akcií

Tianjin Pharmaceutical Da Ren Tang Group Corp Hodnotenie podľa historického KGV, EBIT a KUV

Tianjin Pharmaceutical Da Ren Tang Group Corp Počet akcií CNE000001808 ·

Tržby, EBIT a Zisk na akciu

Tržby na akciu

EBIT na akciu

Príjem na akciu

Očakávané hodnoty

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcie rozdelené

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcia Dividenda CNE000001808 ·

Dividenda

Prehľad dividend

Interpretácia a využitie

Investičná stratégia

Tianjin Pharmaceutical Da Ren Tang Group Corp História dividend

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcia Výplatná kvóta CNE000001808 ·

Výplatná kvóta

Čo je ročná výplatná kvóta?

Ako interpretovať dáta

Použitie údajov pre investície

Tianjin Pharmaceutical Da Ren Tang Group Corp História výplatných kvót

Tianjin Pharmaceutical Da Ren Tang Group Corp Odhad ziskov

Tianjin Pharmaceutical Da Ren Tang Group Corp Prekvapenia zisku

Eulerpool ESG hodnotenie pre akciu Tianjin Pharmaceutical Da Ren Tang Group Corp

Eulerpool World ESG Rating (EESG©)

47/ 100

🌱 Environment

👫 Social

🏛️ Governance

Životné prostredie (Environment)

Sociálne (Social)

Riadenie spoločnosti (Governance)

Tianjin Pharmaceutical Da Ren Tang Group Corp Akcie Štruktúra akcionárov

Tianjin Pharmaceutical Da Ren Tang Group Corp dodávateľský reťazec

Často kladené otázky k akcii Tianjin Pharmaceutical Da Ren Tang Group Corp

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

Ticker
600329.SS

ISIN
CNE000001808